Impaired Apoptosis of Pulmonary Endothelial Cells Is Associated With Intimal Proliferation and Irreversibility of Pulmonary Hypertension in Congenital Heart Disease

Journal of the American College of Cardiology

Volumn 49, Issue 7, 2007, Pages 803-810

  Lévy, Marilyne ^a,b   Maurey, Christelle ^a   Celermajer, David S ^c   Vouhé, Pascal R ^b   Danel, Claire ^a   Bonnet, Damien ^b   Israël Biet, Dominique ^a,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c University of Sydney   (Australia)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL OCCLUSION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; HEART VALVE STENOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFLAMMATION; LUNG; MALE; NEOVASCULARIZATION, PATHOLOGIC; REFERENCE VALUES; TUNICA INTIMA;

EID: 33846925969     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.09.049     Document Type: Article

References (33)

1. Rabinovitch M., Haworth S.G., Castaneda A.R., Nadas A.S., and Reid L.M. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58 (1978) 1107-1122
2. Haworth S.G., and Reid L. A morphometric study of regional variation in lung structure in infants with pulmonary hypertension and congenital cardiac defect. A justification of lung biopsy. Br Heart J 40 (1978) 825-831
3. Vongpatanasin W., Brickner M.E., Hillis L.D., and Lange R.A. The Eisenmenger syndrome in adults. Ann Intern Med 128 (1998) 745-755
4. Stier S., Totzke G., Gruewald E., et al. Identification of p54(nrb) and the 14-3-3 protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. J Biochem Mol Biol 38 (2005) 447-456
5. Sakao S., Taraseviciene-Stewart L., Lee J.D., Wood K., Cool C.D., and Voelkel N.F. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 19 (2005) 1178-1180
6. Matter C.M., Chadjichristos C.E., Meier P., et al. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation 113 (2006) 1879-1887
7. Celermajer D.S., Cullen S., and Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87 (1993) 440-446
8. Dinh Xuan A.T., Higenbottam T.W., Clelland C., Pepke-Zaba J., Cremona G., and Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 99 (1990) 9-10
9. Haworth S.G., and Hislop A.A. Pulmonary vascular development: normal values of peripheral vascular structure. Am J Cardiol 52 (1983) 578-583
10. Kuwano K., Hagimoto N., Tanaka T., et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 190 (2000) 221-229
11. Levy M., Maurey C., Chailley-Heu B., Martinovic J., Jaubert F., and Israel-Biet D. Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung. Pediatr Res 57 (2005) 248-253
12. Budhiraja R., Tuder R.M., and Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 109 (2004) 159-165
13. McMurtry M.S., Archer S.L., Altieri D.C., et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 115 (2005) 1479-1491
14. Takahashi H., Goto N., Kojima Y., et al. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol 290 (2006) L450-L458
15. Dorfmuller P., Perros F., Balabanian K., and Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 22 (2003) 358-363
16. Humbert M., Morrell N.W., Archer S.L., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 13S-24S
17. Rabinovitch M. Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 18 (1999) 1041-1053
18. Teichert-Kuliszewska K., Kutryk M.J., Kuliszewski M.A., et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98 (2006) 209-217
19. Taraseviciene-Stewart L., Scerbavicius R., Choe K.H., et al. Simvastatin Causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 291 (2006) L668-L676
20. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 580 (2006) 2879-2887
21. Yu J., deMuinck E.D., Zhuang Z., et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 102 (2005) 10999-11004
22. Cai J., Jiang W.G., Ahmed A., and Boulton M. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71 (2006) 20-31
23. Kawasaki K., Smith Jr. R.S., Hsieh C.M., Sun J., Chao J., and Liao J.K. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 23 (2003) 5726-5737
24. Berger R.M., Geiger R., Hess J., Bogers A.J., and Mooi W.J. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. Am J Respir Crit Care Med 163 (2001) 1493-1499
25. Mason N.A., Springall D.R., Burke M., et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 185 (1998) 313-318
26. Lam C.F., Peterson T.E., Croatt A.J., Nath K.A., and Katusic Z.S. Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol 289 (2005) H2334-H2341
27. Black S.M., Fineman J.R., Steinhorn R.H., Bristow J., and Soifer S.J. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 275 (1998) H1643-H1651
28. Xia Y., Tsai A.L., Berka V., and Zweier J.L. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273 (1998) 25804-25808
29. Tuder R.M., Chacon M., Alger L., et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195 (2001) 367-374
30. Geiger R., Berger R.M., Hess J., Bogers A.J., Sharma H.S., and Mooi W.J. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 191 (2000) 202-207
31. Grosjean J., Kiriakidis S., Reilly K., Feldmann M., and Paleolog E. Vascular endothelial growth factor signaling in endothelial cell survival: a role for NFkappaB. Biochem Biophys Res Commun 340 (2006) 984-994
32. D'Amico D.J., and VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Pegaptanib sodium for neovascular age-related macular degeneration two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113 (2006) 992-1001
33. Pinto R.F., Higuchi Mde L., and Aiello V.D. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts. Cardiovasc Pathol 13 (2004) 268-275